Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020672 (
hypothermia
)
17,327
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transfusion-related acute lung injury
(
TRALI
) is a serious complication of transfusion and has been ranked as one of the leading causes of transfusion-related fatalities. Nonetheless, many details of the immunopathogenesis of
TRALI
, particularly with respect to recipient factors are unknown. We used a murine model of antibody-mediated
TRALI
in an attempt to understand the role that recipient lymphocytes might play in
TRALI
reactions. Intravenous injection of an IgG2a antimurine major histocompatibility complex class I antibody (34-1-2s) into BALB/c mice induced moderate
hypothermia
and pulmonary granulocyte accumulation but no pulmonary edema nor mortality. In contrast, 34-1-2s injections into mice with severe combined immunodeficiency caused severe
hypothermia
, severe pulmonary edema, and approximately 40% mortality indicating a critical role for T and B lymphocytes in suppressing
TRALI
reactions. Adoptive transfer of purified CD8(+) T lymphocytes or CD4(+) T cells but not CD19(+) B cells into the severe combined immunodeficiency mice alleviated the antibody-induced
hypothermia
, lung damage, and mortality, suggesting that T lymphocytes were responsible for the protective effect. Taken together, these results suggest that recipient T lymphocytes play a significant role in suppressing antibody-mediated
TRALI
reactions. They identify a potentially new recipient mechanism that controls the severity of
TRALI
reactions.
...
PMID:Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury. 2061 20